2014
DOI: 10.1016/s1473-3099(14)70035-0
|View full text |Cite
|
Sign up to set email alerts
|

Rotavirus vaccination in Europe: drivers and barriers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
56
0
5

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(68 citation statements)
references
References 67 publications
7
56
0
5
Order By: Relevance
“…Similar barriers have been identified in many European countries. 38 The ongoing crisis might have further negatively affected the uptake. Likewise, perceived need for vaccination against influenza seems to be low.…”
Section: Discussionmentioning
confidence: 99%
“…Similar barriers have been identified in many European countries. 38 The ongoing crisis might have further negatively affected the uptake. Likewise, perceived need for vaccination against influenza seems to be low.…”
Section: Discussionmentioning
confidence: 99%
“…16 Rotavirus vaccination in countries with established vaccination programmes has consistently and significantly reduced the incidence of rotavirus gastroenteritis (RVGE) and associated hospitalizations, emergency department visits and outpatient/physician office visits in the United States (US), Europe and Australia. [17][18][19][20] Belgium introduced rotavirus vaccination in November 2006, with an uptake of 85% in the first year 21 and 89% in the second year. 22 This high vaccine uptake is maintained throughout subsequent years where parents are asked for a co-payment of the vaccine of 11.6€ per dose.…”
Section: Introductionmentioning
confidence: 99%
“…This result was also in agreement with the fi ndings in the literature (10) (25) . An important reduction in admissions caused by gastroenteritis in children occurred in Europe, even in countries with low immunization coverage, for instance (30) .…”
Section: Methods Of Analysismentioning
confidence: 99%